Related Experiment Video
Updated: Jan 8, 2026

Fecal micro RNA Isolation
Published on: October 28, 2020
Unraveling the Significance of Fecal MicroRNA Profile in Alzheimer's Disease
Kavisha Katuwawala1,2, Prashant Bharadwaj1,2, Ian Martins1,2
1Centre of Excellence for Alzheimer's Disease Research & Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, 6027, Australia.
Abstract:
Alzheimer's disease (AD), a complex neurodegenerative disorder characterised by progressive cognitive decline, affects millions globally. With no current cure, treatment focuses on symptom management and slowing disease progression. Early identification is therefore crucial. Fecal microRNA (miRNA) analysis is emerging as a promising non-invasive diagnostic tool. Evidence suggests that miRNAs present in fecal samples may regulate gene expression linked to AD pathology, impacting cellular functions and disease progression. Dietary factors critically influence gut microbiota composition and diversity, affecting brain health via the gut brain axis. Macronutrients such as carbohydrates, proteins, and fats modulate miRNA expression and gut microbiota, influencing AD risk. High-fat diets can increase inflammation and contribute to AD. This review aims to provide a comprehensive overview of how diet-modulated fecal miRNAs and gut microbiota interplay may serve as novel, non-invasive indicators for early detection and intervention strategies in AD.
Insights
Fecal microRNAs and gut microbiota, influenced by diet, show promise for early Alzheimer's disease detection. This review explores their role as non-invasive indicators for intervention strategies.
Area of Science:
- Neuroscience
- Gastroenterology
- Genetics
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder affecting millions worldwide.
- Current treatments focus on symptom management; early detection is critical for intervention.
- Fecal microRNA (miRNA) analysis offers a promising non-invasive diagnostic approach for AD.
Purpose of the Study:
- To review the interplay between diet-modulated fecal miRNAs and gut microbiota in Alzheimer's disease.
- To explore their potential as novel, non-invasive indicators for early AD detection and intervention.
Main Methods:
- Literature review focusing on diet, gut microbiota, fecal miRNAs, and Alzheimer's disease.
- Analysis of mechanisms linking dietary factors to gut microbiota composition and miRNA expression.
- Examination of the gut-brain axis in the context of AD pathology.
Main Results:
- Dietary components significantly influence gut microbiota and miRNA expression.
- Specific miRNAs in fecal samples correlate with AD pathology and gut-brain axis function.
- High-fat diets are associated with increased inflammation and AD risk.
Conclusions:
- Diet-modulated fecal miRNAs and gut microbiota represent potential non-invasive biomarkers for early AD detection.
- Understanding this interplay can inform novel intervention strategies for Alzheimer's disease.
- Further research is warranted to validate these indicators for clinical application.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
MicroRNAs
MicroRNAs

